Itema | Treatmentb | SEM | P-valuec | |
---|---|---|---|---|
CON | PLS | |||
Saturated FA | ||||
C8:0 | 0.94 | 0.92 | 0.01 | 0.41 |
C10:0 | 2.86 | 2.91 | 0.08 | 0.78 |
C12:0 | 3.80 | 3.75 | 0.07 | 0.76 |
C14:0 | 11.8 | 11.5 | 0.13 | 0.22 |
C15:0 | 1.46 | 1.59 | 0.02 | < 0.01 |
C16:0 | 34.3 | 33.1 | 0.44 | 0.16 |
C18:0 | 11.5 | 11.6 | 0.13 | 0.65 |
Monounsaturated FA | ||||
C16:1 | 1.33 | 1.74 | 0.05 | < 0.01 |
C18:1 trans-10 | 0.53 | 0.44 | 0.01 | < 0.01 |
C18:1 trans-11 | 0.60 | 0.51 | 0.02 | 0.02 |
C18:1 cis-9 | 21.3 | 22.6 | 0.32 | 0.06 |
Polyunsaturated FA | ||||
C18:2 cis-9 cis-12 | 3.23 | 3.16 | 0.03 | 0.38 |
C18:2 cis-9 trans-11 | 0.56 | 0.72 | 0.01 | < 0.01 |
C18:2 trans-10 cis-12 | 0.11 | 0.12 | 0.003 | 0.13 |
C18:3 cis-9 cis-12 cis-15 | 0.39 | 0.47 | 0.01 | < 0.01 |
C20:4 n-6 | 0.13 | 0.16 | 0.002 | < 0.01 |
C20:5 n-3 | 0.058 | 0.062 | 0.004 | 0.30 |
C22:6 n-3 | 0.051 | 0.057 | 0.002 | 0.19 |
Other FAc | 4.91 | 4.73 | 0.06 | 0.56 |
Total FA | ||||
Sum of SFA | 67.9 | 66.2 | 0.39 | 0.04 |
Sum of UFA | 32.1 | 33.8 | 0.39 | 0.04 |
Sum of MUFA | 27.4 | 28.8 | 0.35 | 0.05 |
Sum of PUFA | 4.66 | 4.90 | 0.05 | 0.03 |
Sum of n-6 FA | 3.98 | 3.92 | 0.05 | 0.51 |
Sum of n-3 FA | 0.51 | 0.60 | 0.01 | < 0.01 |
Sum of trans-C18:1 | 1.69 | 1.53 | 0.02 | < 0.01 |
Sum of MCFA | 52.9 | 51.6 | 0.47 | 0.16 |
Sum of LCFA | 43.2 | 44.6 | 0.47 | 0.18 |
PUFA/SFA ratio | 0.07 | 0.08 | 0.001 | 0.02 |
n-6/n-3 FA ratio | 7.89 | 6.76 | 0.12 | < 0.01 |
DI C14:1/(C14:0 + C14:1)d | 0.28 | 0.30 | 0.004 | 0.01 |
DI C16:1/(C16:0 + C16:1) | 0.037 | 0.051 | 0.002 | 0.02 |
DI C18:1/(18:0 + C18:1) | 0.65 | 0.66 | 0.003 | 0.06 |
DI RA/(VA + RA) | 0.48 | 0.59 | 0.01 | < 0.01 |